Podcasts about pharmaceutical

Why can't you quit your bad habits, no matter how hard you try? And are you ready to uncover the crucial missing link? Josh Trent welcomes Dr. Jud Brewer, Neuroscientist and Psychiatrist, to the Wellness + Wisdom Podcast, episode 758, to reveal how your survival mechanisms hijack your mind, why willpower is NOT the key to quitting bad habits, and how understanding habit formation rewires your brain for lasting change.

Wellness + Wisdom: Liberated Life Series | Episode 757 Join Josh Trent, host of the Wellness + Wisdom Podcast, and Mar, co-host of the Liberated Life Series, as they expose why people pleasing and being nice are a fear-based survival response, how somatic recognition and body awareness can help you shift from people-pleaser to unapologetically you, and how your body shows you when you're being inauthentic. We ALL have problems. Stop hiding. Start living life liberated. Learn how to set yourself free from self-sabotage, limiting beliefs, thoughts, and behaviors so you will have lifelong confidence and clarity of purpose through a thriving community and practical tools, guiding you to play a new reality game. Join Josh and others in the Liberated Life Tribe to: Discover lifelong confidence, clarity, and a true sense of purpose with practical tools and a supportive community. Learn to rewrite your reality + master a new “reality game.” Unlock your highest potential in your physical, mental, emotional, spiritual + financial SELF beyond your wildest dreams through accessing the power of surrender to trust life + create new results. Join the Tribe Today (It's FREE)

In this episode of FYI, Chief Futurist, Brett Winton, and Analyst Nemo Marjanovic speak with Alex Zhavoronkov, founder and CEO of Insilico Medicine. Together, they explore the promise of artificial intelligence in transforming the drug discovery process—cutting years off timelines and dramatically reducing costs. Alex shares Insilico's journey from algorithm-first beginnings to a full-stack AI-driven biotech company, highlighting their unique “pan flute” model approach to drug development and the vision of building a “pharmaceutical superintelligence.” The discussion touches on Insilico's clinical progress, including a molecule that recently completed a Phase 2 trial, and how its generative platforms are helping to tackle complex diseases with a focus on longevity.Key Points From This Episode:00:00:00 AI's promise in streamlining the drug discovery process00:03:06 The economics of preclinical development and AI's role in optimization00:04:43 Potential cost and timeline reductions: $2.4B down to $600M, 13 years to 800:07:39 Comparing Insilico's approach to peers like Recursion and AbSci00:10:35 Literature-driven vs. biology-driven models in drug discovery00:13:07 Why a dominant AI platform could reshape biotech industry consolidation00:14:57 Why biologics may be more suited to AI than small molecules00:17:35 Alex Zhavoronkov on founding Insilico and his mission in longevity science00:21:00 From algorithms to real drugs: Insilico's transition to clinical development00:23:15 Managing the pace of AI progress vs. the slow cycle of experimental validation00:27:10 How “pharmaceutical superintelligence” enables prompt-to-drug workflows00:32:26 Validation, trust, and why Insilico runs on both old and frontier models00:39:22 The “pan flute” architecture: stacking specialized models with reinforcement learning00:42:36 Building and training a unified multimodal model for chemistry and biology00:45:32 Public data, clean pipelines, and Insilico's automated validation lab00:50:47 The business model behind Insilico: selling candidates and licensing platforms00:55:12 Why pharma buyers care more about data room quality than pricing01:00:25 On profitability, licensing success, and the dream of a self-sustaining AI biotech01:01:38 Longevity and the search for fundamental mechanisms of aging

The market has reversed the losses of yesterday and is on track for the best day in more than two weeks. Laura is solo to reflect on the session where the financial sector has performed well as have real estate stocks rebounding from the recent losses after th interest rate hold decision. Lifestyle Communities continued to gain attention, as did Netwealth, and Trump’s potential 200% pharmaceutical tariff saw CSL lose ground. NVIDIA hit milestones and Laura looks to the day ahead. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Pharmaceuticals, one of Australia’s biggest US exports, might be slapped with 200 per cent tariffs; Millions of Qantas customers are being informed what data criminals stole from them; Trump again meets with Israeli Prime Minister Benjamin Netanyahu over Gaza; The death toll from the Texas floods has risen to 109; Kate Middleton attended a state banquet at Windsor Castle in honor of French President Emmanuel Macron. The Quicky is the easiest and most enjoyable way to get across the news every day. And it’s delivered straight to your ears in a daily podcast so you can listen whenever you want, wherever you want...at the gym, on the train, in the playground or at night while you're making dinner. Support independent women's media CREDITS Host/Producer: Cassandra Green Audio Production: Lu HillBecome a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

China eyes stronger ties with Egypt and the Arab world as the country's premier visits Cairo. More than 170 people remain missing in Texas where flash floods claimed at least 110 lives. Washington threatens more tariffs on copper imports and pharmaceuticals.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode from July 2022, Peter dives deep into the topic of bone health and explains why this is an important topic for everyone, from children to the elderly. He begins with an overview of bone mineral density, how it's measured, how it changes over the course of life, and the variability between sexes largely due to changes in estrogen levels. From there he provides insights into ways that one can improve bone health, from exercise to nutrition supplements to drugs. Additionally, Peter discusses what happens when one may be forced to be sedentary (e.g., bedrest) and how you can work to minimize the damage during these periods. While this original episode is an AMA, it is available in full to all listeners as a special rebroadcast. We discuss: Overview of bone health topics to be discussed [2:30]; Bones 101: bone function, structure, and more [6:15]; Bone mineral density (BMD), minerals in bone, role of osteoblasts and osteoclasts, and more [9:30]; The consequences of poor bone health [14:30]; The devastating nature of hip fractures: morbidity and mortality data [18:00]; Where fractures tend to occur in the body [23:45]; Defining osteopenia and osteoporosis [25:30]; Measuring BMD with DEXA and how to interpret scores [28:00]; Variability in BMD between sexes [35:15]; When should people have their first bone mineral density scan? [37:45]; How BMD changes throughout the life and how it differs between men and women [40:15]; How changes in estrogen levels (e.g., menopause) impact bone health [45:15]; Why HRT is not considered a standard of care for postmenopausal bone loss [49:00]; Factors determining who may be at higher risk of poor bone health [52:00]; Common drugs that can negatively impact BMD [55:45]; How children can optimize bone health and lay the foundation for the future [59:30]; Types of physical activity that can positively impact bone health [1:03:30]; How weight loss can negatively impact bone health and how exercise can counteract those effects [1:12:15]; Nutrition and supplements for bone health [1:16:00]; Pharmaceutical drugs prescribed for those with low BMD [1:18:45]; Impact of extreme sedentary periods (e.g., bedrest) and how to minimize their damage to bone [1:23:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

The Sackler family didn't just create the opioid crisis—they engineered the most sophisticated population control experiment in human history. Behind their billion-dollar pharmaceutical empire lies a dark truth that connects to government black projects, consciousness suppression programs, and the systematic drugging of entire populations for reasons far more sinister than profit. This explosive investigation reveals how the Sackler dynasty's OxyContin empire was never just about addiction—it was about creating a chemically dependent population that could be easily controlled and manipulated. We're talking about deliberate mind-altering compounds, government collaboration in mass drugging programs, and connections to classified research into human consciousness modification. Our deep-dive exposé uncovers never-before-revealed documents showing how the Sackler family worked with shadowy government agencies to test experimental compounds on unwitting populations, how their pharmaceutical networks connect to missing persons cases and unexplained behavioral changes in entire communities, and how the opioid crisis was designed to suppress humanity's natural psychic abilities and spiritual awareness. From their secretive family meetings to their underground research facilities, we expose how the Sacklers became the enforcement arm of a much larger conspiracy involving population control, consciousness suppression, and the systematic destruction of human potential. Their victims weren't just addiction statistics—they were test subjects in a massive experiment designed to keep humanity docile and unaware. Mystery enthusiasts and truth-seekers know that some epidemics aren't natural—they're engineered. The Sackler investigation reveals how one family weaponized medicine to create a chemically lobotomized population incapable of questioning authority or perceiving the hidden realities around them. We'll expose their connections to mind control research, their role in suppressing alternative healing methods, and their systematic targeting of communities that showed signs of heightened awareness or spiritual awakening. This isn't just about corporate greed—it's about the deliberate chemical warfare against human consciousness itself. From prescription pads to morgue slabs, from rehab centers to research labs, this episode reveals how the Sackler empire operated as humanity's drug dealers, systematically poisoning millions while claiming to heal them. The opioid crisis wasn't a side effect—it was the intended outcome. Stream exclusively on Spreaker for uncensored bonus content about the family's secret research programs, or find us on Amazon Music (ask your Alexa about Sackler conspiracies), Apple Podcasts, Spotify, iHeartRadio, and everywhere truth-seekers get their pharmaceutical reality checks. Some medicine is designed to make you sicker—this episode tells you why.

Thank you for tuning in for another episode of Life's Best Medicine. Dr. Carl Rothschild is the founder, researcher, and owner of Trifecta Light Technologies, Inc., the industry leader in the LED Infrared/Red Light therapeutic heating light lamp modality. He is widely considered one of the world's top thought leaders in LED Infrared/Red Light science and products. In this episode, Drs. Brian and Carl talk about… (00:00) Intro (04:46) How Dr. Carl first became aware of amazing benefits of red light therapy (08:10) Some of the ways light therapy can be used to heal the body (15:07) Why practically everyone benefits from red light therapy (20:03) The mechanisms by which red light works in the body to increase fat-loss (22:00) How near infrared light stimulates the mitochondria (29:06) The fat-loss benefits of red light therapy (37:57) How red light therapy works to repair skin (38:59) Red light therapy for athletes (43:53) Pharmaceutical drugs (45:10) Red light therapy for Parkinson's Disease (46:16) Red light therapy side effects and why it still remains a fringe treatment modality (49:51) Insulin resistance and red light therapy (51:42) Staying healthy and increasing your health span (55:22) Using other therapies in conjunction with red light (59:05) Outro For more information, please see the links below. Thank you for listening!   Links:   Dr. Carl Rothschild: IG: https://www.instagram.com/trifectalightofficial/ FB: https://www.facebook.com/trifectalightofficial YouTube: https://www.youtube.com/@trifectalightofficial Trifecta Light: https://trifectalight.com Illuminated Healing (book): https://trifectalight.com/books/   Dr. Brian Lenzkes:  Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/   HLTH Code: HLTH Code Promo Code: METHEALTH • • HLTH Code Website: https://gethlth.com

Listen in as our expert panel discusses practical considerations for starting and optimizing antidepressants for treating depression and anxiety.  You'll listen to panelists cover various aspects of antidepressant use, such as serotonin syndrome, QT prolongation, and weight gain concerns.Special guest(s):Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP Director of Pharmacy and Residency Programs, New York State Office of Mental Health State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences Sarah E. Grady, PharmD, BCPS, BCPPProfessor, Drake University College of Pharmacy and Health SciencesClinical Pharmacist, Inpatient Behavioral Health Unit, Broadlawns Medical CenterYou'll also hear practical advice from TRC's Editorial Advisory Board member:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in May 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights.Clinical Resources: Choosing AntidepressantsSwitching AntidepressantsCombining and Augmenting AntidepressantsPharmacotherapy of Anxiety Disorders in AdultsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode of IDD Health Matters, host Dr. Craig Escudé interviews A.J. Forster, a professional with over a decade of experience supporting individuals with intellectual and developmental disabilities (IDD). Forster shares his journey from working in finance to becoming passionate about serving the IDD population through direct support and leadership roles. Now at Tarrytown Pharmacy, he helps streamline medication services for IDD providers, aiming to relieve the burden on nurses and staff by coordinating refills, prior authorizations, and emergency prescription needs. He emphasizes the importance of interdisciplinary teams, especially in managing psychotropic medications with regular reviews to avoid unnecessary treatments and reduce side effects. Forster also highlights the value of direct support professionals, advocating for better pay and recognition, and underscores the need for emergency preparedness across care systems. Throughout, the conversation spotlights collaboration, proactive care, and a mission-driven approach to improving the lives of people with IDD.

Ozempic is one of the most import new medications in a generation. The scientist who created it is a self-described "nerd," who grew up on a farm in Denmark and has no interest in the limelight. Lotte Knudsen started her career working on laundry detergent enzymes, but eventually joined a team at the Danish pharmaceutical company Novo Nordisk that was tasked with looking for new treatments for diabetes. She was convinced that a recently discovered human hormone called GLP-1 could be made into a powerful medication, not only for Type 2 diabetes, but also for weight loss. It took 20 years of hard work and persistence for her and her team to figure it out, but their creation now shows promise as a worthy foe of heart disease, kidney disease, Parkinson's, alcoholism & Alzheimer's as well. In this episode Lotte Knudsen tells her story, and we hear from two of the other scientists who made critical contributions to this revolution in medicine: Mads Thomsen and Daniel Drucker.

Stupid News Extra 6-27-2025 …Japanese Pharmaceutical Company Wants Your Feces

Struggling to lose weight despite doing everything right?In this powerful episode of Sweat Success, we sit down with Dr. Aly Cohen, a triple board-certified physician and environmental health expert, to uncover the real reason why so many people can't see results… even with proper diet and training.We go beyond calories and cardio to reveal how hidden toxins in your food, water, personal care products, and environment may be disrupting your hormones, storing more fat, and blocking your gym results. If you're on a journey toward fat loss, better health, and long-term performance, this is the episode you need to hear.Whether you're a coach, athlete, or someone working hard to feel better, this conversation with Dr. Aly Cohen will give you new tools and a fresh perspective on what actually creates health.

Do you want to have power in controlling your wellbeing? Choosing a pharmacy team that mets your needs is essential. Phil Hauser, pharmacist and owner of Hauser's Health Care guides us on how to maximize your pharmacies services to assist you in reaching your wellbeing goals. Phil shares practical advice from his knowledge and expertise in the industry. Advice to guide you in selecting the pharmacy that best suits your needs, communication tips, how to maximize services available and information on understanding half lives of your medication.Your pharmacy team is knowledge and easily accessible to help you. Take the time to learn what they have to offer. It is time of visit your pharmacy, communicate your needs and take steps forward in your health. Your pharmacy, your choice, your powerhouse!POPULAR VIDEOS

 In my whole life, I believe in existing other beings on other planets that are smarter than human beings… Even, I think that is so easily possible… When 50% of the Americans believe in a Lunatic. Or in Germany, they vote, again and again, for M, and expect that she is doing something good … And that is alone the proof that there must be something smarter than human beings…That the USA government is covering up all data and evidence of UFOs shows that they are afraid of more intelligent beings… I could fill books with proofs, but it bores me…When you deny something, then in the first place, you have to assume that there is something that you deny. For instance, you think there is no God… Why you think so? Because you assume there is God otherwise you would not try to prove that there is no God…Until today, I could not identify any Alien, nor I was in relationships with some Alien… The only Alien I  know that is me … I feel so like an Alien, I trust in God, and that is insane and live a total healthy lifestyle, and this combination is the proof that I am an Alien… I don't believe in Medical Doctors and Pharmaceutical because their intention will not fit an Alien body… It looks so weird that the Medical Doctors and Pharmaceutical earn a fortune to make people chronicle ill.And human beings like to torture their body with pharmaceutical, wrong medical treatments, junk food, and hate a healthy lifestyle…As Alien I can not believe what I see… If you don't live stupid, you can't be a human. Believe that… The most important question is, Why should Aliens visit the Earth? Because they have great humor and alone to visit the world for a week, make them laugh for decades…If we see miracles (buildings, tools) that the Aliens have created on the earth… For what? To have fun… And afterward, we pretend our best that everything we have done… And we never got any help… Isn't it funny? My Video: Do UFOs exist? https://youtu.be/Z5fUPWpJa0wMy Audio: https://divinesuccess.net/wp-content/uploads/2021/Podcast.B/Do-UFOs-exist.mp3

IBJ calls for Hogsett resignation. Welcome to the party IBJ, Pharmaceutical company planning to relocate from California to Fishers, Le Peep rebrands to Maple, Nearly 1 million illegal immigrants have 'self deported' under Trump, Big Beautiful Bill riding on SALT, Rokita first state AG to threaten private colleges over DEI, echoing Trump with Harvard, Time to end the Ayatollah regimeSee omnystudio.com/listener for privacy information.

Last night's Pacers game was rough to watch, Is the US about to go on a bombing run on Iran? Maneuvers in the Middle East, Is the US bringing the bunker buster with them? Trump smacking down Macron, It's a scam! Trump wants blue cities targeted for deportation first, IBJ calls for Hogsett's resignation. States agree to $7.4 billion settlement with Purdue Pharma in opioid litigation, Trump wants an end not a ceasefire, Get Your Happy Meal Purse, They should have done the deal. The Iranians need to topple the Ayatollah. IBJ calls for Hogsett resignation. Welcome to the party IBJ, Pharmaceutical company planning to relocate from California to Fishers, Le Peep rebrands to Maple, Nearly 1 million illegal immigrants have 'self deported' under Trump, Big Beautiful Bill riding on SALT, Rokita first state AG to threaten private colleges over DEI, echoing Trump with Harvard, Time to end the Ayatollah regime See omnystudio.com/listener for privacy information.

On this episode of Reaganism, Reagan Institute Director Roger Zakheim sits down with Dr. Tevi Troy, a senior fellow at the Reagan Institute and former deputy secretary of Health and Human Services. They discuss Dr. Troy's article 'In Praise of Big Pharma,' exploring the critical role of the pharmaceutical industry in healthcare innovation and the challenges it faces from government regulation and public perception. The conversation also touches on the importance of vaccines, the impact of government policies on healthcare costs, and the future of American innovation in the pharmaceutical sector, particularly in the context of competition with China.

Join me, Charles River's Miriam Guest, and independent consultant Vanessa Figueroa as we tackle the role of a microbiologist in drug manufacturing. Who is keeping patients safe from contamination, and how are they making sure our life saving drugs are not contaminated? How is manufacturing like yoga? Find out by listening now!

Ian Bremmer, president of the Eurasia Group, joins "CBS Mornings" to break down a weekend of deep division in the U.S., as millions protested President Trump and his military parade, and deadly new strikes between Iran and Israel raised fears of a wider regional war in the Middle East. The jury in Karen Read's retrial began deliberations Friday afternoon and will continue Monday. Read is facing three charges in the 2022 death of her police officer boyfriend, John O'Keefe, including second-degree murder. Her first trial ended with a hung jury. Pharmaceutical giant Eli Lilly announced a price cut for its drug, Zepbound, for people who aren't using insurance. CBS News' Nancy Chen reports on the qualifications for the discount and what the cost reduction will be. Artificial intelligence is being used to create realistic video and audio to impersonate people, in some cases looking for love or deceiving companies looking to hire. In a 2024 study, half of the businesses surveyed said they'd experienced AI deepfake fraud. CBS News MoneyWatch correspondent Kelly O'Grady reports. In this week's "Beg-Knows America," CBS News contributor David Begnaud revisits the life-changing world of high school speech and debate, an activity that shaped his own path. He meets the inspiring young voices featured in the new documentary "SPEAK," tackling grief, identity, and advocacy with extraordinary courage. Consumer Reports' deputy editor Brian Vines joins "CBS Mornings" to share the latest sunscreen testing results, including top-rated picks and expert tips to keep you and your family safe in the sun this summer. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

睽違半年Happy Hour總算更新啦！這次若晴跟Angel來聊聊最近剛從研討會回來的一些見聞和心得，非常適合搭配上一集新手村005一起收聽！當然我們也不忘Happy Hour的慣例，跟大家分享了一則近期非常振奮人心的客製化基因療法突破的新聞。等待Happy Hour已久的聽眾趕緊收聽吧！ 節目內容： 跟大家更新一下近況 客製化基因療法大突破 芝加哥三腳貓4/6小聚 AACR開幕式小花絮 跟同事學了poster session的搜集資訊的招數 小廢物拿好拿滿還有免費專業大頭照 NIH fellowship小會議見聞 會議結識新朋友的喜悅 -- Hosting provided by SoundOn

Aaron Alt, CFO at Cardinal Health (CAH), joins Diane King Hall at the NYSE set to discuss the company's financial outlook. He describes the drugmaker's share buyback plans and recent FY25 guidance raise. Alt says the company's recent strategic acquisitions help broaden the company's healthcare reach, including glucose monitoring for diabetes treatment.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Over the Counter to discuss the potential impact pharmaceutical tariffs may have on pharmacies if they are to be widely implemented in the near future.

During this episode, Santosh is joined by Joel Wayment, VP and GM of 3PL logistics at Cardinal Health. Joel provides an in-depth exploration of pharmaceutical cold chain logistics, highlighting the critical evolution of medical product transportation. He discusses how emerging technologies, sustainability efforts, and innovative packaging solutions are transforming the supply chain, particularly for ultra-sensitive medical products like cell and gene therapies. Joel also emphasizes the importance of minimizing product touches, leveraging AI and data insights, and creating environmentally friendly shipping solutions. Key takeaways include the role of technology in improving supply chain visibility, the impact of disruptions like COVID-19 on logistics innovation, the ongoing challenge of getting critical medical products safely and efficiently from manufacturers to patients, and so much more. Highlights from their conversation include:Cardinal Health Overview (1:10)Joel's Background and Journey (1:58)Evolution of Cold Chain Logistics (2:49)Advancements in Packaging Solutions (4:43)Visibility and Transparency in Shipping (5:40)Patient-Centric Approaches (7:30)Monitoring Product Conditions (9:20)Sustainability in Packaging (11:14)Consolidation and Optimization Strategies (14:52)Lessons from Supply Chain Disruptions (16:41)Balancing Regulation and Flexibility (19:40)Data Insights for Accountability (21:46)The Role of AI in Logistics (24:45)Proactive Decision-Making with Data (26:54)Final Thoughts and Takeaways (28:13)Dynamo is a VC firm led by supply chain and mobility specialists that focus on seed-stage, enterprise startups.Find out more at: https://www.dynamo.vc/

Section 232 comments on pharmaceutical and semiconductor investigations are available for review. Listen for more on Two Minutes in Trade. 

What if I told you that everything we believed about vaccine safety was built on manipulated data that pharmaceutical companies never wanted us to see? In this interview, I sat down with Dr. Aseem Malhotra, renowned British cardiologist, who reveals how independent analysis of Pfizer's original trial data showed you were more likely to suffer serious harm from the vaccine than be hospitalized with COVID at a rate of 1 in 800. Dr. Malhotra walks me through his co-founded Hope Accord petition signed by tens of thousands of medical professionals calling for a moratorium, how politicians were systematically misled, and why trust in medicine has plummeted to historic lows. Join my FREE 3-Day Ultimate Detox Challenge starting June 23rd.: ⁠https://bit.ly/3ZgCW4u⁠ Join the Ultimate Human VIP community today!: ⁠https://bit.ly/4ai0Xwg⁠ Connect with Dr. Aseem Malhotra: Website: ⁠https://bit.ly/4dCGKRZ⁠  YouTube: ⁠https://bit.ly/4jKLGal⁠  Instagram: ⁠https://bit.ly/4dFY2gY⁠  Facebook:⁠https://bit.ly/48ghD6F⁠  TikTok: ⁠https://bit.ly/4eZyHjr⁠  X.com: ⁠https://bit.ly/4eXnL5O⁠  Thank you to our partners: H2TABS - USE CODE “ULTIMATE10” FOR 10% OFF: ⁠https://bit.ly/4hMNdgg⁠ BODYHEALTH - USE CODE “ULTIMATE20” FOR 20% OFF: ⁠http://bit.ly/4e5IjsV⁠ BAJA GOLD - USE CODE "ULTIMATE10" FOR 10% OFF: ⁠https://bit.ly/3WSBqUa⁠ EIGHT SLEEP - SAVE $350 ON THE POD 4 ULTRA WITH CODE “GARY”: ⁠https://bit.ly/3WkLd6E⁠ COLD LIFE - THE ULTIMATE HUMAN PLUNGE: ⁠https://bit.ly/4eULUKp⁠ WHOOP - GET 1 FREE MONTH WHEN YOU JOIN!: ⁠https://bit.ly/3VQ0nzW⁠ MASA CHIPS - GET 20% OFF YOUR FIRST ORDER: ⁠https://bit.ly/40LVY4y⁠ VANDY - USE CODE “ULTIMATE20” FOR 20% OFF: ⁠https://bit.ly/49Qr7WE⁠ AION - USE CODE “ULTIMATE10” FOR 10% OFF: ⁠https://bit.ly/4h6KHAD⁠ HAPBEE - FEEL BETTER & PERFORM AT YOUR BEST: ⁠https://bit.ly/4a6glfo⁠ CARAWAY - USE CODE “ULTIMATE” FOR 10% OFF: ⁠https://bit.ly/3Q1VmkC⁠ HEALF - GET 10% OFF YOUR ORDER: ⁠https://bit.ly/41HJg6S⁠ BIOPTIMIZERS - USE CODE “ULTIMATE” FOR 10% OFF: ⁠https://bit.ly/4inFfd7⁠ RHO NUTRITION - USE CODE “ULTIMATE15” FOR 15% OFF: ⁠https://bit.ly/44fFza0⁠ GENETIC TEST: ⁠⁠https://bit.ly/3Yg1Uk9⁠ Connect with Gary Brecka: Instagram: ⁠https://bit.ly/3RPpnFs⁠ TikTok: ⁠https://bit.ly/4coJ8fo⁠ YouTube: ⁠⁠https://bit.ly/3RPQYX8⁠ X.com: ⁠https://bit.ly/3Opc8tf⁠ Facebook: ⁠https://bit.ly/464VA1H⁠ Website: ⁠https://bit.ly/4eLDbdU⁠ Merch: ⁠https://bit.ly/4aBpOM1⁠ Newsletter: ⁠https://bit.ly/47ejrws⁠ Timestamps: 00:00 ​Intro of Show 02:55 COVID-19 Vaccine Moratorium Petition Discussion 07:10 Historical vaccine withdrawals (swine flu, rotavirus) 09:40 COVID-19 Vaccine Moratorium Petition Current Status 20:11 Call for medical establishment apology & acknowledgment 24:52 Pharmaceutical manipulation vs. political misleading 29:31 Psychological barriers to accepting uncomfortable truths 34:19 Individual methylation differences and spike protein clearance 36:07 The realizations of the COVID propaganda campaigns 41:09 Treatment protocols for vaccine-injured patients 45:35 Framingham Study revelations 55:44 Dr. Malhotra's clinical approach to cholesterol management 01:00:15 Inflammation as root cause vs. cholesterol theory 01:09:16 Dr. Malhotra opinion on public health policy 01:17:48 ​What does it mean to you to be an Ultimate Human? The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is day two of our special anniversary series + we are welcoming Melissa Ward back to the show! This conversation is from February of 2024, and was one of my favorite episodes! Melissa and I talked about her career in the pharmaceutical industry, how she started blogging, how to always be growing, and not get stuck in your ways. Melissa is a mom who lives in North Carolina with her husband and two kids. Armed with a degree in Fashion and Textile Management from NC State University, Melissa's career journey took an unexpected turn when she went to work for start-up pharmaceutical companies for over 10 years following graduation.In 2020 Melissa begin her own small business journey part-time. Fueled by her passion for finding deals on items for home, style, and kids, she decided to start her own blog and Instagram account, @preppygoods.Before long, Melissa took the plunge to full-time content creation, transforming her love for discovering budget-friendly hidden-gems into a career. Her curated content revolves around showcasing finds from major retailers like Amazon, Walmart, and Target, as well as highlighting lesser-known treasures from small businesses.Whether you're into home decor, fashion inspiration, or kid-friendly goodies, Melissa has you covered. You can explore her curated picks for preppy grandmillennials on her website, www.preppygoods.com, or connect with her on social media platforms such as Instagram, TikTok, and Pinterest, all under the handle @preppygoods. Y'all are going to love my episode with Melissa!Melissa's WebsiteMelissa's InstagramSarah's Smile

About this episode: Would it be a good idea to have tariffs on pharmaceuticals? In this episode: a conversation about the rationales for tariffs as well as potential downsides—like higher drug prices—and what could really help with supply and pricing issues. Guest: Dr. Mariana Socal studies the pharmaceutical market and is an associate professor in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains—Johns Hopkins Carey Business School Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages—NBC Los Angeles Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Our guest on this week's episode is Michael Needham, principal procurement & supply chain at Efficio Consulting. Among the flurry of executive orders issued recently by the White House is one aimed at restoring pharmaceutical manufacturing capabilities here in the U.S. Currently most drugs and ingredients are manufactured in China and India. How will such a move affect supply chains? Our guest offers his views on what can be manufactured here easily and what could be more difficult.Measuring the health of our supply chains, the Logistics Manager's Index came out on Tuesday, showing an expansion in logistics activity in May. Logistics expanded for the second straight month, marked by a mix of slowing inventory levels and rising costs across the board, researchers said. We look at the specific numbers and what they mean.This week we saw a study on workplace injuries. This report came from the Travelers Companies. It found that the number of workplace injuries overall continues to decline, although the costs associated with them are climbing. We dive into some of the details of the report and how emphasizing safety can affect the workplace. Supply Chain Xchange  also offers a podcast series called Supply Chain in the Fast Lane.  It is co-produced with the Council of Supply Chain Management Professionals. All episodes are available to stream now. Go to your favorite podcast platform to subscribe and to listen to past and future episodes. The podcast is also available at www.thescxchange.com.Articles and resources mentioned in this episode:OfficioMay 2025 Logistics Managers' IndexWorkplace injury rate drops, but costs riseVisit Supply Chain XchangeListen to CSCMP and Supply Chain Xchange's Supply Chain in the Fast Lane podcastSend feedback about this podcast to podcast@agilebme.comPodcast is sponsored by: Storage SolutionsOther linksAbout DC VELOCITYSubscribe to DC VELOCITYSign up for our FREE newslettersAdvertise with DC VELOCITY

Here in Episode #37, podcast host Dr. Jerry Workman speaks with Dr. Austin Daniels, application scientist for Yokogawa Fluid Imaging Technologies. This Episode will focus on flow imaging microscopy (FIM), a new technology for subvisible particle characterization in biologics. We have invited Austin to our Analytically Speaking podcast to discuss the current trends and state of using FIM to ensure the quality and safety of biologics. This requires precise monitoring of subvisible particles, which can impact drug efficacy and patient health. Traditional analysis methods, such as light obscuration (LO) and membrane microscopy (MM), provide limited data on particle types and morphology, making it difficult to pinpoint contamination sources.

Send us a textA critique of SSRIs and pharma's influence on medicine, including SSRI-induced sexual dysfunction, suicidality, and violence. Long Summary: Dr. David Healy critiques modern medicine, focusing on SSRIs and psychiatric medicine, including: how pharmaceutical companies manipulate clinical trial data, ghostwrite studies, and influence medical practice, often ignoring patient experiences; highlighting issues like post-SSRI sexual dysfunction (PSSD), the immediate sensory effects of SSRIs, and their potential to induce suicidal or violent behavior; challenging the reliance on randomized controlled trials (RCTs) over individual patient reports; and more.About the guest: David Healy, MD, PhD, a psychiatrist and pharmacologist, has decades of experience researching the serotonin system and SSRIs, working across Ireland, the UK, Canada, and the US. He is a professor at McMaster University and a vocal critic of pharmaceutical industry practices.Discussion Points:SSRIs cause near-immediate sensory effects, like genital numbing, in most people.Post-SSRI sexual dysfunction (PSSD) can persist for years or decades after stopping the drug, affecting many long-term users.Healy argues RCTs prioritize averages over individual experiences, often missing serious side effects like suicidality.Pharmaceutical companies ghostwrite studies and manipulate data, with journals like the New England Journal of Medicine publishing misleading articles.Serotonin theory of depression lacks evidence.Industry tactics include dismissing patient reports as anecdotes and using high doses in trials to mask weak efficacy.SSRIs can increase suicide risk, not just during initiation but also when adjusting doses or withdrawing, as seen in cases like the Aurora movie theater shooting.Regulatory bodies like the FDA often fail to investigate adverse effects due to bureaucratic processes and lack of follow-up.Healy emphasizes doctors' failure to prioritize patient observations, driven by industry-influenced standards of care.Related episode:M&M 88: Depression, Serotonin, SSRIs, Psychiatry & Social Media | Joanna Moncrieff*Not medical advice.Support the showAll episodes, show notes, transcripts, and more at the M&M Substack Affiliates: KetoCitra—Ketone body BHB + potassium, calcium & magnesium, formulated with kidney health in mind. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off Readwise: Organize and share what you read. 60 days FREE through link SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. MASA Chips—delicious tortilla chips made from organic corn & grass-fed beef tallow. No seed oils or artificial ingredients. Code MIND for 20% off For all the ways you can support my efforts

Gemma started her career studying Mechanical Engineering at Cardiff University. She quickly discovered the world of Continuous Improvement and spent 20 years working to improve processes and systems within various manufacturing industries including Automotive, Pharmaceutical, Dairy, Cosmetics & Toiletries, Food, and Medical Devices. She has been a CI Manager numerous times and an Operations Manager running a factory of over 500 people.Gemma is hugely passionate about Improvement and developing people and processes. She gets such a kick out of coaching and facilitating, especially when she sees the lightbulb switch on in someone's head – when they solve a problem; when they realize they have the power to change; or when they get excited about all the improvements they could make.In 2019, Gemma left the world of employment to establish her own business, SPARK Improvement, aiming to switch on as many lightbulbs as possible. Her mission is to help organizations and individuals be the BEST they can be, by helping people SEE, helping people THINK, and helping people CHANGE.Gemma is based in Cheshire in the UK, working globally.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Tune in as Glenn Hunzinger, PwC's Health Industries Leader, and Phil Scalfani, PwC's Pharmaceutical and Life Sciences Consulting Leader, discuss the Trump administration's executive order on Most Favored Nation (MFN) drug pricing and its far-reaching implications across the healthcare ecosystem. They break down what MFN pricing could mean for pharmaceutical companies, payers, PBMs, and the broader drug supply chain, and share perspectives on how organizations can navigate the uncertainty ahead.  Discussion Highlights: The MFN executive order is a bold attempt to lower U.S. drug prices by benchmarking them against the lowest prices paid in other high-income countriesPharma companies may be forced to rethink global pricing strategies, balancing U.S. price cuts with potential increases or market exits abroadA proposed shift to direct-to-consumer drug access could disrupt traditional roles for pharmacies, distributors, and pharmacy benefit managers (PBMs)Companies are preparing for significant uncertainty by reassessing deals, modeling financial impacts, and closely monitoring upcoming rulemaking and potential legal developmentsSpeakers:Glenn Hunzinger, Health Industries Leader, PwCPhilip Sclafani, Partner, Pharma & Life Sciences, PwCLinked materials:Most Favored Nation prescription drug pricing Executive OrderFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development.In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discuss how existing ethical frameworks are being challenged by the rise of generative AI and why maintaining human oversight is critical—especially in high-context areas like clinical trial design, consent and medical communications. Karla also shares her views on the future of data privacy, the complexity of patient agency and how to avoid losing trust in the race for efficiency.Karla is a strong advocate for using innovation responsibly. From her work with internal bioethics committees to her perspective on evolving regulatory expectations, she offers bold insights into how the industry can modernize without compromising ethics or equity.Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.

Listen in as our expert panel discusses medications for the treatment of Alzheimer dementia.  They'll review the risks and benefits of cholinesterase inhibitors, memantine, and the anti-amyloid monoclonal antibodies.  And you'll hear strategies for managing behavioral and psychological symptoms of dementia.   Special guests:Tatyana Gurvich, PharmD, BCGP, APhAssociate Professor of Clinical PharmacyMann USC School of PharmacyUCI Senior Health CenterCandace Pierce, DNP, RN, CNE, COINurse Educator, Nurse Planner, and Healthcare LeaderColibri HealthcareDarlene Moyer, MD, FAAFPAssociate Director, HonorHealth Family Medicine Residency ProgramAssociate Professor of Clinical Practice – SOMME – Arizona State UniversityClinical Associate Professor – University of Arizona College of Medicine - PhoenixYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in April 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ - Alzheimer Dementia Pharmacotherapy Chart – Pharmacotherapy of Dementia BehaviorsChart - Drugs with Anticholinergic ActivityChart - Send us a textCheck out our NEW podcasts.Rumor vs TruthYour trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.Clinical CapsulesTRC editors break down the most impactful clinical developments - giving you clear, actionable takeaways in just minutes.If you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

The Strange Murders of the Wealthiest Murder Victims in History. Who killed the Billionaire Pharmaceutical CEO Barry and Honey Sherman? Why were their bodies placed in odd positions? Was a hitman hired by a Pharmaceutical company? To watch the podcast on YouTube: ⁠⁠⁠⁠⁠https://bit.ly/TheoriesOfTheThirdKindYT⁠⁠⁠⁠⁠ - Get instant access to 200+ bonus Audio episodes - Sign up here: ⁠⁠⁠⁠⁠https://theoriesofthethirdkind.supercast.com⁠ To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

References NeuroMolecular Medicine2024. Volume 26,article 2.J of Neurochemistry 2018. V146, Issue4 August:416-428Rimsky-Korsikov. 1888. Scheherazade OP 35https://music.youtube.com/watch?v=zY4w4_W30aQ&si=9Q0bhwIdpY2aZ5yFAnderson, J. 1971 ".Your Move ". YEShttps://music.youtube.com/watch?v=WfgPEh2J9aI&si=QeKguSCVouRgjhR7

Tune in as Glenn Hunzinger, PwC's Health Industries Leader, connects with Matt Rich, PwC's Pharma and Life Sciences R&D Leader, to unpack the recent disruption at the FDA and what it means for the pharmaceutical and biotech sectors. They discuss how companies can stay agile in the face of regulatory uncertainty, avoid preventable delays, and take practical steps to move programs forward with clarity.Discussion highlights:Ongoing restructuring at the FDA is creating uncertainty and delays in drug and device approvals, with wide-ranging impacts across the pharma, biotech and medtech landscape.While companies can't control the regulatory environment, they can focus on improving internal speed, efficiency, and submission quality to keep programs moving forwardAvoiding preventable missteps, or “foot faults,” in data, endpoints, and submission packages is critical to reducing review delays and regulatory pushbackDiversifying risk by pursuing parallel regulatory pathways in other regions such as Europe and Japan can help accelerate access and reduce dependency on a single agencyIn the absence of a clear playbook, companies should focus on what they can control by applying past lessons, staying disciplined, and collaborating across the industry to support more efficient FDA review processesSpeakers:Matt Rich, PwC's Pharmaceutical and Life Sciences R&D LeaderGlenn Hunzinger, Partner, Health Industries Leader, PwCLinked materials:Navigating the FDA disruption: 4 key actions for pharmaFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune in as Glenn Hunzinger, PwC's Health Industries Leader and Roel van den Akker, PwC's Pharma and Life Sciences Deals Leader discuss the rapid rise of China's biotech industry and what it means for U.S. pharmaceutical companies. They discuss the evolving role of Chinese biotech in the global innovation landscape and share perspectives on how U.S. pharmaceutical companies can thoughtfully assess opportunities, manage cross-border complexities, and build effective partnering and diligence strategies.  Discussion highlights:China's biotech industry is growing fast and becoming a global player, with U.S. companies increasingly looking to partner with Chinese firms on cutting-edge scienceU.S. pharma leaders are encouraged to move beyond skepticism and stay curious by building relationships, learning from local innovation, and exploring new partnership opportunitiesSuccessfully partnering with Chinese biotech firms requires a careful and well-structured approach that accounts for global complexity, protects data and IP, and uses creative deal structures like new company formations to manage risk and stay flexibleU.S. companies need to be proactive in order to stay competitive by actively exploring global innovation, understanding the risks, and having a clear strategy to bring high-potential science to U.S. patientsSpeakers:Roel Van den Akker, Pharmaceutical and Life Sciences Deals Leader Glenn Hunzinger, Partner, Health Industries Leader, PwCLinked materials:China's rise as a biotech innovation hub: 4 key strategic questions for US biopharma executivesFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Rich welcomes Dr. Sebastian Gorka, deputy assistant to President Trump and senior director for counter terrorism at the National Security Council, to talk about the 'Golden Dome' defense system and other matters of national security. Next, Regeneron Pharmaceuticals is buying 23andMe for $256 million; we get reaction from Dr. Steven Quay, founder of Atossa Therapeutics. We also talk tariffs and China with Kerry Lutz, best-selling author of host of Financial Survival Network. Plus, Dr. Elaine Healy, whom you may recall as a COVID whistleblower, tells why she has informed Delaware authorities of the possible elder abuse of former President Joe Biden. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Join Charles River experts Sandy Kimber, Charlotte Cumper, and Claire Richards from our Portishead site for a discussion on what makes some viruses more contagious than others, how viruses can trick your immune system, and how vaccines can affect viral spread.

Today, I am joined by Nisha Narang of Soulful Vegan and Leorah Clinical. Nisha is an experienced Pharmaceutical and Clinical Research Professional pioneering ethical innovation in healthcare development. With a Bachelor of .Pharmacy and Master of .Science. in Biochemical Pharmacology, Nisha has over 15 years of expertise in managing clinical research projects across regulatory guidelines and therapeutic areas.Her unique vision of combining scientific rigor with cruelty-free principles led to establishing Leorah Clinical, the world's first dedicated vegan-friendly clinical development consultancy. Through her leadership, Leorah Clinical helps companies develop innovative healthcare products that maintain excellence while adhering to ethical principles.Nisha's expertise spans clinical research and development, regulatory compliance, vegan-friendly innovation, and global project management, enabling Leorah Clinical to deliver comprehensive solutions that transform the future of healthcare development.In addition to her pioneering work at Leorah Clinical, Nisha is a passionate advocate for plant-based living. Through her coaching platform, Soulful Vegan, she empowers individuals to embrace a healthier lifestyle by offering personalized guidance on vegan nutrition and wellness. Her coaching sessions are rooted in compassion and tailored to help clients achieve their health goals while respecting their unique journeys.To connect with Nisha:For Vegan Product Development: Collaborate with Nisha to bring your cruelty-free product ideas to life. Book a consultation here- https://www.leorahclinical.com/consultation/For Science-Based Vegan Health Coaching: Start your journey toward optimal health with personalized coaching plans. Choose a plan that works for you here- https://soulfulvegan.com.au/coaching/To connect with me:Follow me on Facebook and Instagram @didyoubringthehummusFor more info on my Public Speaking 101 program: ⁠https://www.didyoubringthehummus.com/publicspeakingforactivists⁠Contact me here or send me an email at info@didyoubringthehummus.comSign up for meditation sessions hereSign up for The Vegan Voyage, to sponsor the podcast, book meditations packages, or sign up for my Public Speaking program hereJoin my Podcast Fan Facebook Group: https://www.facebook.com/groups/didyoubringthehummus/To be a guest on the podcast: https://www.didyoubringthehummus.com/beaguest©2025 Kimberly Winters - Did You Bring the Hummus LLCTheme Song ©2020 JP Winters ⁠@musicbyjpw⁠

In this episode, I sit down with Shay Domangue, PA-C, whose career path took a bold and inspiring turn — from hospitalist PA/ internal medicine to building her own social media business in elder care to transitioning to marketing development in the pharmaceutical device industry. She's now the Gulf Coast Field Market Development Specialist in the Renal Denervation business unit for Medtronic and is also raising two little humans (with her husband's help).Shay shares what it was like to reach a breaking point in clinical medicine and how listening to that inner voice led her to explore something new. She didn't just walk away — she walked toward a more aligned, values-based life and career.We talk about the early days of entrepreneurship, the emotional and logistical challenges of building something from scratch, and the surprising role that networking played in her transition into the pharmaceutical industry.Shay opens up about redefining success, protecting her energy, and how work-life balance has become a non-negotiable in her new chapter. She also drops some hard-earned wisdom for clinicians who are feeling stuck or wondering what else is out there — especially if you've ever thought, “I can't do this for 20 more years.”This conversation is for you if you're craving purpose, dreaming of flexibility, or just want to hear from someone who's made a major pivot and lived to tell the tale.CONNECT WITH SHAY:Linkedin.com/in/shaydomangueShay's polypharmacy info on TikTok: @elder.care.hubHOPE'S BOOK:⁠⁠Healing Clinician Burnout, How to Revive Your Life and Career ⁠⁠(available in ebook and paperback)CONNECT AND SIGN UP FOR COACHING:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's Website: www.coachhopecook.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's IG @coachhopecook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's FB @hopeallencook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's LinkedIn: hope-cook-56041283/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's YouTube @coachhopecook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Email: hope.cook@gmail.comLove y'all, and remember: There's always hope!

051325 Scott Adams Show, Trump Pharmaceutical EO, Trump in Riyadh, Democrats in Chaos

- Broadcast News Introduction and Upcoming Segments (0:00) - AI Advancements and Their Impact on Jobs (0:45) - Breaking News: Trump-China Trade Deal and Its Implications (2:46) - Pakistan-India Cyber War and Its Potential Escalation (9:55) - Power Grid Vulnerabilities and Preparedness (13:36) - Crypto Wallets and the Importance of Self-Custody (19:04) - AI Capabilities and Their Implications for Human Jobs (25:14) - The Role of Enoch AI in Empowering Users (59:30) - The War on Human Cognition and Its Vectors (1:05:29) - Strategies for Protecting Cognitive Function (1:21:34) - Chemotherapy and Cognitive Impairment (1:21:56) - Natural Light and Sun Exposure (1:25:06) - Media and Information Warfare (1:30:33) - Societal and Behavioral Factors (1:33:37) - Defending Against Environmental Toxins (1:41:05) - Nutritional and Dietary Factors (1:47:00) - Pharmaceutical and Medical Warfare (1:49:22) - EMF Exposure and Technological Risks (1:59:51) - Information Warfare and Censorship (2:02:12) - Societal and Behavioral Factors (2:11:11) - Zionist and Chinese Strategic Moves in the Middle East (2:25:45) - Trump's Arrogance and Military Presence in Panama (2:26:04) - China's Influence and Economic Strategy in Panama (2:26:21) - Strategic Importance of the Panama Canal (2:52:23) - Strait of Hormuz and Global Energy Supply (3:06:20) - US-China Trade War and Economic Implications (3:14:03) - Anthropological Warfare and Cultural Resilience (3:14:21) - Migration and Demographic Warfare (3:22:15) - Global Economic and Political Dynamics (3:28:51) - Future Strategic Moves and Predictions (3:33:17) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

We kick-off the week with a LIVE press conference from President Trump on a new proposal by the administration to lower drug prices, news on tariffs/China, and a preview of a pivotal case sitting before the Supreme Court. Plus ~ important context to a now viral exchange between the Department of Homeland Security Secretary and Senator Van Hollen (D-MD) over the fate of Kilmar Abrego Garcia.  SUPPORT OUR MISSION: Love nonpartisan news? Want a bigger serving of the serious headlines?  Here's how you can become a SCOOP insider: https://www.scoop.smarthernews.com/get-the-inside-scoop/    Shop our gear!  Instagram: https://www.instagram.com/smarthernews/  Website: https://smarthernews.com/  YouTube Channel: https://www.youtube.com/smarthernews 

We take a deep dive into the lesser-known industry of “pharmacy benefits managers” (PBMs) which are parasitical companies that sit in the middle of the incredibly consolidated and vertically integrated market of pharmaceuticals hospitals insurers pharmacy benefits managers pharmacies. Through the simple administrative business of making lists of drugs and networks of pharmacies, PBMs have managed to carve out a multi-billion dollar rent-seeking industry premised on controlling (and jacking up) how much drugs cost and where you can get them—and extracting as much money as possible from people who need those drugs. ••• Timeline of FTC lawsuit against PBMs and relevant documents: https://www.ftc.gov/legal-library/browse/cases-proceedings/221-0114-caremark-rx-zinc-health-services-et-al-matter-insulin ••• Concurring Statement of Commissioner Andrew N. Ferguson https://www.ftc.gov/system/files/ftc_gov/pdf/Ferguson-Statement-Pharmacy-Benefit-Managers-Report.pdf ••• Market Power and Inequality: The Antitrust Counterrevolution and Its Discontents | Lina Khan and Sandeep Vaheesan https://scholarship.law.columbia.edu/faculty_scholarship/2790/ ••• Inside the Mafia of Pharma Pricing | Matt Stoller https://www.thebignewsletter.com/p/inside-the-mafia-of-pharma-pricing ••• A brief look at current debates about pharmacy benefit managers https://www.brookings.edu/articles/a-brief-look-at-current-debates-about-pharmacy-benefit-managers/ Standing Plugs: ••• Order Jathan's new book: https://www.ucpress.edu/book/9780520398078/the-mechanic-and-the-luddite ••• Subscribe to Ed's substack: https://substack.com/@thetechbubble ••• Subscribe to TMK on patreon for premium episodes: https://www.patreon.com/thismachinekills Hosted by Jathan Sadowski (bsky.app/profile/jathansadowski.com) and Edward Ongweso Jr. (www.x.com/bigblackjacobin). Production / Music by Jereme Brown (bsky.app/profile/jebr.bsky.social)